A new approach to RNA sequencing reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers. Advancing technology is allowing scientists increasingly to search for tiny signs of cancer and other health issues in samples of patients’ blood and urine. These “liquid biopsies” are less invasive than a traditional biopsy, and can provide information about what’s happening throughout the body instead of just at a single site.

For more information about this story visit: https://labblog.uofmhealth.org/health-tech/making-invisible-visible-new-method-opens-unexplored-realms-for-liquid-biopsies

Hosted on Acast. See acast.com/privacy for more information.